OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-10-31-accounts

REGISTERED CHARITY NUMBER: 1101433
Report of the Trustees and
Financial Statements
for the Year Ended 31 October 2021
for

EPSOM MEDICAL RESEARCH

Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

EPSOM MEDICAL RESEARCH

Contents of the Financial Statements
for the Year Ended 31 October 2021
Page
Report of the Trustees 1 to 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Balance Sheet 5
Notes to the Financial Statements 6 to 10
Detailed Statement of Financial Activities 11

EPSOM MEDICAL RESEARCH

Report of the Trustees

for the Year Ended 31 October 2021
Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityfortheyear ended
31October2021.ThetrusteeshaveadoptedtheprovisionsofAccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordance with
the FinancialReportingStandardapplicablein the UK and Republicof Ireland(FRS 102)(effective1 January
2019).

OBJECTIVES AND ACTIVITIES

Objectives and aims

TheobjectivesoftheEpsomMedicalResearchareinthefieldofresearchwithintheareas of
rheumatology, general medicine, inflammation, neuroscience and cancer.

ACHIEVEMENT AND PERFORMANCE

Charitable activities in the year

The Charity supported research into the areas defined in its objectives during the year.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

Thecharityiscontrolledbyitsgoverningdocument,adeedoftrustandconstitutesan unincorporated
charity.

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Charity number

1101433

Principal address

85 Rydens Road
Elmbridge
Walton-on-Thames
Surrey
KT12 3AN

Trustees

Dr. L G Darlington
Ms S Kumar
K W D Ramsey

Independent Examiner

Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
Page 1

EPSOM MEDICAL RESEARCH

Report of the Trustees

for the Year Ended 31 October 2021
Approved by order of the board of trustees on 22 August 2022 and signed on its behalf by:
Dr. L G Darlington - Trustee
Page 2
Independent Examiner's Report to the Trustees of
Epsom Medical Research

Independent examiner's report to the trustees of Epsom Medical Research

I reporttothecharitytrusteesonmyexaminationoftheaccountsofEpsomMedicalResearch(the Trust)
for the year ended 31 October 2021.

Responsibilities and basis of report

AsthecharitytrusteesoftheTrustyouareresponsibleforthepreparationoftheaccountsin accordance
with the requirements of the Charities Act 2011 ('the Act').
I reportin respectofmyexaminationoftheTrust'saccountscarriedoutundersection145oftheAct and
incarryingoutmyexaminationIhavefollowedallapplicableDirectionsgivenbytheCharity Commission
under section 145(5)(b) of the Act.

Independent examiner's statement

Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometomyattention in
connection with the examination giving me cause to believe that in any material respect:

1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or

2. the accounts do not accord with those records; or

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which
attentionshouldbedrawninthisreportinordertoenableaproperunderstandingoftheaccountsto be
reached.
Mr Ryan Cottington
FCCA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
22 August 2022
Page 3

EPSOM MEDICAL RESEARCH

Statement of Financial Activities

for the Year Ended 31 October 2021

2021
Unrestricted
fund
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
47,105
EXPENDITURE ON
Charitable activities
Grants
37,276
Other
1,645
Total
38,921
NET INCOME/(EXPENDITURE)
8,184
RECONCILIATION OF FUNDS
Total funds brought forward
(213,538)
TOTAL FUNDS CARRIED FORWARD
(205,354)
2020
Total
funds
£
45,395
62,465
1,682
64,147
(18,752)
(194,786)
(213,538)
The notes form part of these financial statements
Page 4

EPSOM MEDICAL RESEARCH

Balance Sheet

31 October 2021

2021
Unrestricted
fund
Notes
£
CURRENT ASSETS
Debtors
4
8,420
Cash at bank
14,496
22,916
CREDITORS
Amounts falling due within one year
5
(228,270)
NET CURRENT ASSETS/(LIABILITIES)
(205,354)
TOTAL ASSETS LESS CURRENT LIABILITIES
(205,354)
NET ASSETS/(LIABILITIES)
(205,354)
FUNDS
6
Unrestricted funds
(205,354)
TOTAL FUNDS
(205,354)
2020
Total
funds
£
9,288
10,382
19,670
(233,208)
(213,538)
(213,538)
(213,538)
(213,538)
(213,538)
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
22 August 2022 and were signed on its behalf by:
L G Darlington - Trustee
The notes form part of these financial statements
Page 5
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements
for the Year Ended 31 October 2021

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsin accordance
withtheFinancialReportingStandardapplicableintheUKandRepublicofIreland(FRS 102)
(effective1January2019)',FinancialReportingStandard102'TheFinancialReporting Standard
applicableintheUKandRepublicofIreland'andtheCharitiesAct2011.Thefinancial statements
have been prepared under the historical cost convention.

Income

Allincomeis recognisedin theStatementofFinancialActivitiesoncethecharityhasentitlement to
the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthe charityto that expenditure,it is probablethat a transferof economicbenefitswill  be
requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is
accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost
relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have
been allocated to activities on a basis consistent with the use of resources.
Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a
commitment but not accrued as expenditure.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the
trustees.
Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial
statements.
continued...
Page 6
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements - continued
for the Year Ended 31 October 2021

2. TRUSTEES' REMUNERATION AND BENEFITS

Therewere no trustees'remunerationor otherbenefitsfor the year ended 31 October2021nor for
the year ended 31 October 2020.

Trustees' expenses

Therewerenotrustees'expensespaidfortheyearended31October2021norfortheyear ended
31 October 2020.

3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricte
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies 45,395
EXPENDITURE ON
Charitable activities
Grants 62,465
Other 1,682
Total 64,147
NET INCOME/(EXPENDITURE) (18,752)
RECONCILIATION OF FUNDS
Total funds brought forward (194,786)
TOTAL FUNDS CARRIED FORWARD (213,538)
continued...
Page 7
for the Year Ended 31 October 2021

EPSOM MEDICAL RESEARCH

Notes to the Financial Statements - continued

4.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Other debtors
5.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Other creditors
Accruals and deferred income
6.
MOVEMENT IN FUNDS
At
1/11/20
£
Unrestricted funds
General fund
(213,538)
TOTAL FUNDS
(213,538)
Net movement in funds, included in the above are as follows:
Incoming
resources
£
Unrestricted funds
General fund
47,105
TOTAL FUNDS
47,105
2021
2020
£
£
8,420
9,288
2021
2020
£
£
208,610
208,610
19,660
24,598
228,270
233,208
Net
movement
At
in funds
31/10/21
£
£
8,184
(205,354)
8,184
(205,354)
Resources
Movement
expended
in funds
£
£
(38,921)
8,184
(38,921)
8,184
continued...
Page 8
Notes to the Financial Statements - continued
for the Year Ended 31 October 2021

EPSOM MEDICAL RESEARCH

6. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Unrestricted funds
General fund
TOTAL FUNDS
Comparative net movement in funds, included in the above a
Unrestricted funds
General fund
TOTAL FUNDS
At
1/11/19
£
(194,786)
(194,786)
re as follows:
Incoming
resources
£
45,395
45,395
Net
movement
At
in funds
31/10/20
£
£
(18,752)
(213,538)
(18,752)
(213,538)
Resources
Movement
expended
in funds
£
£
(64,147)
(18,752)
(64,147)
(18,752)
r
A current year 12 months and prior year 12 months combined position is as follows:
Unrestricted funds
General fund
TOTAL FUNDS
At
1/11/19
£
(194,786)
(194,786)
Net
movement
in funds
£
(10,568)
(10,568)
At
31/10/21
£
(205,354)
(205,354)
continued...
Page 9
Notes to the Financial Statements - continued
for the Year Ended 31 October 2021

EPSOM MEDICAL RESEARCH

6. MOVEMENT IN FUNDS - continued

Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in
the above are as follows:
Unrestricted funds
General fund
TOTAL FUNDS
Incoming
Resources
Movement
resources
expended
in funds
£
£
£
92,500
(103,068)
(10,568)
92,500
(103,068)
(10,568)

7. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 October 2021.
Page 10

EPSOM MEDICAL RESEARCH

Detailed Statement of Financial Activities

for the Year Ended 31 October 2021
INCOME AND ENDOWMENTS
Donations and legacies
Donations
Gift aid
Legacies
Total incoming resources
EXPENDITURE
Charitable activities
Research salaries
Research expenses
Support costs
Governance costs
Accountancy and legal fees
Total resources expended
Net income/(expenditure)
2021
£
33,682
8,423
5,000
47,105
47,105
32,300
4,976
37,276
1,645
38,921
8,184
2020
£
36,316
9,079
-
45,395
45,395
34,062
28,403
62,465
1,682
64,147
(18,752)
This page does not form part of the statutory financial statements
Page 11